|
시장보고서
상품코드
2077280
광견병 항혈청 시장 : 종류별, 용도별, 유통 채널별, 지역별Rabies Antiserum Market, By Type, By Application, By Distribution Channel, By Geography |
||||||
광견병 항혈청 시장은 2026년에 13억 7,000만 달러 규모가 될 것으로 추정되며, 2033년까지 17억 4,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 3.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 13억 7,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 3.50% | 2033년 시장 규모 예측: | 17억 4,000만 달러 |
광견병 항혈청은 광견병이 의심되는 동물과 접촉한 사람들을 보호하기 위해 사용됩니다. 광견병은 감염된 동물의 타액을 매개로, 물림이나 긁힘을 통해 사람이나 다른 동물에게 전염되는, 중증이며 거의 100% 치명적인 질병입니다. 감염 후에는 즉시 의료 처치를 받고 예방접종을 받으면 예방할 수 있습니다. 고위험 지역으로 여행하시는 분들은 노출 전 광견병 백신 접종 과정을 완료하고, 만일 감염된 동물에게 물리거나 할퀴는 경우를 대비하여 노출 후 예방 조치(PEP)를 미리 준비해 두는 것이 권장됩니다. 사용 가능한 광견병 면역글로불린에는 인간용 광견병 면역글로불린(HRIG)과 말용 광견병 면역글로불린(ERIG)의 두 가지 종류가 있습니다. 구할 수 있다면 HRIG가 바람직하지만, 구할 수 없는 경우에도 ERIG는 광견병 바이러스를 중화시키는 효과가 있습니다.
시장 역학:
광견병 예방에 대한 수요와 개에 의한 물림 사고의 증가가 광견병 항혈청 시장의 성장을 견인할 것으로 예상됩니다. 또한, 광견병 백신 접종에 대한 인식이 높아지는 것도 시장 성장을 촉진할 것으로 예상됩니다. 또한, 기술의 발전과 소비자 행동의 변화 역시 예측 기간 동안 시장의 성장을 이끄는 주요 요인이 될 것입니다.
한편, 첨단 기술에 대한 인식 부족이 시장 성장을 저해할 것으로 예상됩니다. 정부의 공중보건 기관이나 국제 기구들이 펼치는 인식 제고 활동이 제한적이라는 점도 시장 성장을 저해하고 있습니다. WHO에 따르면, 2021년에는 109개국 이상에서 사람과 동물 모두에게서 광견병 사례가 보고되었습니다. 그러나 많은 저소득 국가에서는 실제 발생 상황을 정확하게 기록하기 위한 국가 감시 체계가 미흡했습니다. 공식적으로 이용 가능한 정확한 역학 데이터가 없기 때문에 광견병이 초래하는 진정한 위협은 과소평가되기 쉽습니다. 이는 항혈청 등의 생물학적 제제 공급을 포함하여, 광견병 예방 프로그램을 확대하는 데 필요한 정책적 관심과 자원을 동원하는 데 큰 장애물이 되고 있습니다.
본 조사의 주요 특징:
- 이 조사는 다양한 부문에서 잠재적인 수익 기회를 밝혀내고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 광견병 항혈청 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 '세계 광견병 항혈청 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 광견병 항혈청 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 광견병 항혈청 시장 : 유형별, 2021-2033년
제5장 광견병 항혈청 시장 : 용도별, 2021-2033년
제6장 광견병 항혈청 시장 : 유통 채널별, 2021-2033년
제7장 광견병 항혈청 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.07.08Rabies Antiserum Market is estimated to be valued at USD 1.37 Bn in 2026 and is expected to reach USD 1.74 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.37 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.50% | 2033 Value Projection: | USD 1.74 Bn |
Rabies antiserum is used to protect people who have been exposed to a potentially rabid animal. Rabies is a serious, almost always fatal disease that spreads from the saliva (spit) of an infected animal through a bite or scratch to humans and other animals. It can be prevented by getting immediate medical care and immunizations after the exposure. It is recommended that travelers to high-risk areas have a pre-exposure rabies vaccine series and be prepared with post-exposure prophylaxis (PEP) in case they are bitten or scratched by an infected animal. There are two types of rabies immunoglobulin available: human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG). HRIG is preferable when it is available, but if it is not, ERIG will be effective in neutralizing the rabies virus.
Market Dynamics:
The need to prevent rabies and the rising incidence of dog bites are expected to support growth of the rabies antiserum market. Additionally, the growing awareness regarding rabies vaccinations is also expected to propel growth of the market. Moreover, technological advancements and changing consumer behavior are other major factors expected to drive growth of the market over the forecast period.
On the other hand, a lack of awareness regarding advanced technology is expected to restrict market growth. Limited efforts by government public health agencies and international organizations towards awareness-generation activities have also restricted market growth. According to the WHO, in 2021, over 109 countries reported rabies cases in both humans and animals. But national surveillance systems were weak to reliably record the true incidence in many poorer nations. Without accurate epidemiological data available in the public domain, the real threat posed by rabies tends to get underestimated. This acts as a major roadblock in mobilizing necessary policy attention and resources for expanding rabies prevention programs, including the supply of biologics like antiserum.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global rabies antiserum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum Institute of India Ltd., Green Cross Corp., Haffkine, Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., and Beijing Tiantan Biological Products Co. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rabies antiserum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rabies antiserum market
Detailed Segmentation:
- Rabies Antiserum Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Monoclonal Antibodies (mAbs)
- Polyclonal Antibodies
- Rabies Antiserum Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Pre-Exposure Prophylaxis (PrEP)
- Post-Exposure Prophylaxis (PEP)
- Rabies Antiserum Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- CSL Behring
- Sanofi Pasteur
- Grifols S.A.
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG (China National Biotec Group) Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rabies Antiserum, By Type
- Market Rabies Antiserum, By Application
- Market Rabies Antiserum, By Distribution Channel
- Market Rabies Antiserum, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising incidence of dog bites
- Growing awareness regarding rabies vaccinations
- Restraints
- Lack of awareness regarding advanced technologies
- Opportunities
- Supportive government initiatives
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rabies Antiserum Market , By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Monoclonal Antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Rabies Antiserum Market , By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Pre-Exposure Prophylaxis (PrEP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Post-Exposure Prophylaxis (PEP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
6. Rabies Antiserum Market , By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
7. Rabies Antiserum Market , By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2026 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Grifols S.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bharat Serum and Vaccines Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kedrion Biopharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biogenesis Bago SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Serum Institute of India Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shanghai Institute of Biological Products Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CNBG (China National Biotec Group) Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Harbin Pharmaceutical Group Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beijing Tiantan Biological Products Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
